Genelux Corporation - Enterprise Value

The Enterprise Value as of June 2026 (TTM) for Genelux Corporation (GNLX) is 104.76M

According to Genelux Corporation’s latest financial reports and current stock price. The company's current Enterprise Value is 104.76M. This represents a change of -14.57% compared to the average of 122.62M of the last 4 quarters.

Genelux Corporation (GNLX) Historical Enterprise Value (quarterly & annually)

How has GNLX Enterprise Value performed in the past?

The mean historical Enterprise Value of Genelux Corporation over the last ten years is 175.29M. The current 104.76M Enterprise Value has changed 5.88% with respect to the historical average. Over the past ten years (40 quarters), GNLX's Enterprise Value was at its highest in in the June 2023 quarter at 820.73M. The Enterprise Value was at its lowest in in the June 2024 quarter at 48.98M.

Genelux Corporation (GNLX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Genelux Corporation Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Genelux Corporation (GNLX) Average Enterprise Value

How has GNLX Enterprise Value performed in the past?

The current Enterprise Value of Genelux Corporation (GNLX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Genelux Corporation (GNLX) Enterprise Value vs. Peers

How is GNLX’s Enterprise Value compared to its peers?

Genelux Corporation’s Enterprise Value is greater than Aldeyra Therapeutics, Inc. (68.74M), less than Silence Therapeutics plc (321.81M), less than Alpha Tau Medical Ltd. (889.28M), less than Candel Therapeutics, Inc. (263.19M), less than AC Immune S.A. (182.10M), greater than Mereo BioPharma Group plc (13.16M), less than Lyell Immunopharma, Inc. (255.36M), less than Cellectis S.A. (295.12M), less than Contineum Therapeutics, Inc. Class A Common Stock (433.19M), less than Lexeo Therapeutics, Inc. Common Stock (322.71M),

Build a custom stock screener for Genelux Corporation (GNLX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Genelux Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Genelux Corporation (GNLX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Genelux Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.